Covered recipient · General Payments record
TANYA SARA ANNE TEMPLE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$2,041.28
- Reported across 87 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $816.54 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $453.76 | 16 |
| REVANCE THERAPEUTICS, INC. | $136.04 | 1 |
| MERZ NORTH AMERICA, INC. | $128.69 | 1 |
| Galderma Laboratories, L.P. | $98.05 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $6.94 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108295380 | CMS |
| ABBVIE INC. | $10.69 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108295382 | CMS |
| ABBVIE INC. | $8.93 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108295384 | CMS |
| ABBVIE INC. | $17.78 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108295386 | CMS |
| ABBVIE INC. | $120.87 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108295388 | CMS |
| ABBVIE INC. | $11.12 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108295390 | CMS |
| ABBVIE INC. | $25.50 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108295392 | CMS |
| ABBVIE INC. | $27.64 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108295394 | CMS |
| ABBVIE INC. | $13.76 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108295396 | CMS |
| ABBVIE INC. | $5.09 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108295398 | CMS |
| ABBVIE INC. | $142.76 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108295400 | CMS |
| ABBVIE INC. | $18.90 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108295402 | CMS |
| ABBVIE INC. | $19.30 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108295404 | CMS |
| ABBVIE INC. | $6.52 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108295406 | CMS |
| ABBVIE INC. | $11.50 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108295408 | CMS |
| ABBVIE INC. | $6.46 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108295410 | CMS |
| Galderma Laboratories, L.P. | $98.05 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145396091 | CMS |
| MERZ NORTH AMERICA, INC. | $128.69 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146394573 | CMS |
| REVANCE THERAPEUTICS, INC. | $136.04 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147952124 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.